F-08 · Barrier Repair

Phosphatidylcholine

phosphatidylcholine
Egg yolk, sunflowerEgg yolk, sunflower
F-08 · #58

Phosphatidylcholine

BodyBio, PC (phosphatidylcholine) · 100 softgels
BarrierInflammation

The phospholipid that makes up most of the colonic mucus layer, and is measurably depleted in UC. A delayed-release PC (LT-02) had three positive Heidelberg trials in chronic active UC (pooled remission odds ratio 9.7), then a 466-patient phase 3 program was stopped for futility in 2023: deep remission 14% on LT-02 versus 13.5% on placebo. It was never sold. Neither supplement here is delayed-release: BodyBio is a liposomal phospholipid complex, Thorne a standard softgel. The biology holds; the trial form does not exist to buy.

Both soy-derived. Loose stool at high doses.
References 109–112
Andrew's notes

A 4 rather than a 5 only because of the negative trial. I continue to see good results and have never seen anything negative. I do wonder whether any downside comes from the same kind of oxidative stress we worry about with seed oils. Two products here; neither is a delayed-release formulation, and the one that was (LT-02) was a drug candidate that never reached the market.

SKU
KAN-SP600
Also
Thorne Phosphatidyl Choline, go.supplementsforibd.com/phosphatidylcholine-2
Evidence3

Positive early UC trials of a drug form; a negative phase 3

Andrew's score4

Andrew's judgment, 1–5.

A phosphatidylcholine (POPC)
A phosphatidylcholine (POPC) · C42H82NO8P · 760.1 g/mol · PubChem CID 5497103

At a glance

Mucus-layer phospholipid depleted in UC
References 109–112

Product options from the guide

References

  1. Stremmel W, Merle U, Zahn A, Autschbach F, Hinz U, Ehehalt R. Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis. Gut 2005;54(7):966–971.
  2. Stremmel W, Braun A, Hanemann A, Ehehalt R, Autschbach F, Karner M. Delayed release phosphatidylcholine in chronic-active ulcerative colitis: a randomized, double-blinded, dose finding study. J Clin Gastroenterol 2010;44(5):e101–e107.
  3. Stremmel W, Vural H, et al. Delayed-release phosphatidylcholine is effective for treatment of ulcerative colitis: a meta-analysis. Dig Dis 2021;39(5):508. (3 RCTs, 160 patients; remission OR 9.68.)
  4. Modified-release phosphatidylcholine (LT-02) for ulcerative colitis: two double-blind, randomized, placebo-controlled trials. Clin Gastroenterol Hepatol 2023. PMID 37806372. (PCG-2 terminated for futility; 466 randomized; deep remission 13.5% placebo vs 14.2% and 9.7% on LT-02.)

READ & SHOP

Explore related supplements

Browse all 100 →

Vitamins & Minerals

Choline

Direct precursor to phosphatidylcholine (F-08). In the multivitamin.

Evidence 1/5Andrew —/5
Read entry →No product selected

Barrier Repair

Butyrate

Butyric acid itself (not the sodium or calcium salt) in a sustained-release form designed to survive the small intestine and reach the colon, which is the entire…

Evidence 3/5Andrew 4/5

Options to explore with your care team. These are not a recommendation to take them together. Andrew earns a commission on Fullscript purchases. US shipping only.